When executed with precision and transparency, ECAs can enhance trial efficiency, expand access and support evidence—while ...

Industry experts gathered at the Outsourcing in Clinical Trials East Coast 2025 conference to discuss artificial intelligence ...

An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the ...

The highly anticipated presentation will be delivered by Francisco Silva, Vice President of Research and Development at ...

China Medical University Hospital (Taiwan) and Shine-On Biomedical Co. developed SOB100, the world's first HLA-G targeted ...

Shares of Sun Pharma Advanced Research Company Ltd (SPARC) plunged nearly 20% on Wednesday on the NSE, after the company ...

The final phase of a clinical trial aiming to treat familial Alzheimer's disease using existing medication for Parkinson's ...

IVMED-85 is a preservative-free, non-atropine daily drop that slows myopia progression by strengthening scleral and corneal ...

A groundbreaking telehealth trial offers remote access to innovative pancreatic cancer treatment, enhancing patient ...

New study tests Parkinson’s drug to treat early-onset familial Alzheimer’s disease, a rare form of dementia, with results ...

MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...

Reducing the length of immunotherapy treatment for an advanced skin cancer did not significantly diminish disease control ...